Feature Channels:

Genetics

Add to Favorites Subscribe Share
fbshare-Genetics

Showing results

110 of 4944
dh_horz_blue_crop.png
  • Embargo expired:
    16-Sep-2019 3:00 PM EDT

Article ID: 718852

Genetic Mutation Appears to Protect Some People from Deadly MRSA

Duke Health

An inherited genetic tendency appears to increase the likelihood that a person can successfully fight off antibiotic-resistant staph infections, according to a study led by Duke Health researchers.

Released:
11-Sep-2019 4:05 PM EDT
Newswise: How cells recycle proteins

Article ID: 718988

How cells recycle proteins

South Dakota State University

A team of scientists will use E. coli cells to help understand how human cells break down excess or unusable proteins into amino acids they can use.

Released:
16-Sep-2019 4:10 AM EDT
Embargo will expire:
17-Sep-2019 11:00 AM EDT
Released to reporters:
13-Sep-2019 9:35 AM EDT

EMBARGOED

A reporter's PressPass is required to access this story until the embargo expires on 17-Sep-2019 11:00 AM EDT

The Newswise PressPass gives verified journalists access to embargoed stories. Please log in to complete a presspass application.
If you have not yet registered, please do so. When you fill out the registration form, please identify yourself as a reporter in order to advance to the presspass application form.

Embargo will expire:
19-Sep-2019 5:00 PM EDT
Released to reporters:
13-Sep-2019 9:00 AM EDT

EMBARGOED

A reporter's PressPass is required to access this story until the embargo expires on 19-Sep-2019 5:00 PM EDT

The Newswise PressPass gives verified journalists access to embargoed stories. Please log in to complete a presspass application.
If you have not yet registered, please do so. When you fill out the registration form, please identify yourself as a reporter in order to advance to the presspass application form.

Research Results

Channels:

All Journal News, Diabetes, Genetics, Kidney Disease

Languages:

English

Newswise: The Genetics of Cancer

Article ID: 718923

The Genetics of Cancer

University of Delaware

A research team has identified a new circular RNA (ribonucleic acid) that increases tumor activity in soft tissue and connective tissue tumors. The discovery may help improve how cancer is identified and treated.

Released:
12-Sep-2019 2:25 PM EDT
PennMed_logo.png

Article ID: 718921

Penn Announces Completion of Exclusive R&D Alliance With Novartis and Development of New Focused Relationship

Perelman School of Medicine at the University of Pennsylvania

The University of Pennsylvania and Novartis have concluded their seven-year research and development alliance, which resulted in the world’s first approved gene therapy for cancer. They will continue to work together on a more narrow CAR T cell therapy clinical trials portfolio.

Released:
12-Sep-2019 2:05 PM EDT
Newswise: Post-Doctoral Associate Named Prestigious Hanna H. Gray Fellow, Receives $1.4 Million Award to Accelerate His Career

Article ID: 718855

Post-Doctoral Associate Named Prestigious Hanna H. Gray Fellow, Receives $1.4 Million Award to Accelerate His Career

Donald Danforth Plant Science Center

Kevin Cox Jr., Ph.D., a post-doctoral associate at the Donald Danforth Plant Science Center was named one of only 15 Hanna H. Gray Fellows by the Howard Hughes Medical Institute (HHMI) in Chevy Chase, MD.

Released:
12-Sep-2019 9:00 AM EDT
coriell_logo_CMYK.jpg

Article ID: 718844

Predictors of Response to Guadecitabine Found in Relapsed/Refractory AML Patients

Coriell Institute for Medical Research

Patients with acute myeloid leukemia (AML), a leukemia which arises from bone marrow tissue, often see remission following their initial treatment, but for patients whose cancer returns, there are few options. One such option is guadecitabine, a novel DNA hypomethylating drug which slows problematic changes to a person’s epigenetic profile, but the drug is ineffective in a select number of relapsed or refractory AML patients and there has not been a way to determine who stands to benefit and who does not. However, researchers from the Coriell Institute for Medical Research have found certain biomarkers which can indicate a patient’s likelihood for success. Their findings were published in Clinical Epigenetics in July.

Released:
12-Sep-2019 8:45 AM EDT
Newswise: HCRI_Buidling_and_Sign1a.jpg

Article ID: 718871

Results Announced for Pioneering Research on the Effect of Mutant Genes on Stuttering Therapy

Hollins Communications Research Institute

Hollins Communications Research Institute (HCRI), a national center for stuttering research and therapy innovation, just completed another research initiative in collaboration with the National Institutes of Health (NIH). The study is the first to evaluate stuttering therapy outcomes among a group of stutterers who possess one of four mutant genes for stuttering in comparison to a group who do not carry the same mutant genes.

Released:
12-Sep-2019 8:20 AM EDT

Announcement

Channels:

Cell Biology, Genetics

Languages:

English

Newswise: New Federal Guidelines for BRCA Testing: Should You Be Screened?

Article ID: 718785

New Federal Guidelines for BRCA Testing: Should You Be Screened?

Cedars-Sinai

More women than ever are being encouraged to undergo screening for BRCA gene mutations, based on newly announced U.S. Preventive Services Task Force recommendations. The task force recommends that:

Released:
12-Sep-2019 6:00 AM EDT

Showing results

110 of 4944

Chat now!